O'Brien P Q, Roberts E F, Lee S K. "Method for the Synthesis of 4-Methyl-5-[1-(4-morpholinyl)ethyl]-2-pyrimidinamine" [P]. US Patent, US 10391542 B2, 2015-02-05.
Johansson L, Lefèvre J P, Sørensen M. "A Process for Preparing High-Purity 4-Methyl-5-[1-(4-morpholinyl)ethyl]-2-pyrimidinamine" [P]. European Patent, EP 3403592 A1, 2023-02-25.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chemosphere, 2022, 1158, 7802-7832.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2023, 511, (12), 5904-5922.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of 4-Methyl-5-[1-(4-morpholinyl)ethyl]-2-pyrimidinamine Using HRMS and NMR". Environ. Sci. Technol., 2012, 402, (1), 5681-5697.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2014, 1768, (9), 72-75.